About Assertio Therapeutics
Assertio Therapeutics (NASDAQ:ASRT) is a specialty pharmaceutical company focused on the development, sale, and marketing of branded prescription products designed to address unmet medical needs. Operating mainly in the United States, Assertio Therapeutics is dedicated to offering innovative solutions in neurology, orphan, and specialty medicines. The company's project portfolio includes a range of drugs aimed at providing effective treatments for conditions such as migraine, pain, and inflammation. Assertio Therapeutics is committed to improving patients' lives by delivering high-quality, innovative medicines that address complex health challenges. Through strategic alliances and groundbreaking research, the company aims to expand its product offerings and strengthen its position in the pharmaceutical industry.
Snapshot
Operations
Produtos e/ou serviços de Assertio Therapeutics
- Pain management medications, focusing on non-opioid treatments.
- Neurology products, targeting neurological disorders.
- Portfolio of generic pharmaceuticals, offering more affordable medication options.
- In-licensing of innovative therapies for unmet medical needs.
- Partnerships for the development of drug delivery technologies.
- Commercialization services, aiding smaller companies in bringing their drugs to market.
equipe executiva do Assertio Therapeutics
- Mr. Paul SchwichtenbergPresident & COO
- Mr. Ajay PatelExecutive VP & CFO
- Mr. Mark L. ReisenauerCEO & Director
- Mr. Sam SchlessingerExecutive VP & General Counsel
- Dr. Howard J. Franklin M.B.A., M.D.Senior Vice President of Medical